Header graphic for print
Dangerous Drugs & Medical Devices News & Commentary on Prescription Drug & Medical Device Lawsuits

Monthly Archives: February 2014

1999 – Large study finds Risperdal linked to hormonal side effects including male breast growth

Posted in Risperdal

Over the last decade or so, a number of articles have been published concerning the link between the use of the atypical antipsychotic drug Risperdal (risperidone) and elevated prolactin levels, ensuing gynecomastia.  (Prolactin is the hormone responsible for breast development and milk production.) Here, we will discuss one such article, published in a 1999 edition… Continue Reading

2003 – Elevated prolactin levels seen in 65% of Risperdal patients

Posted in Risperdal

In 2003, the results of a small study titled “Risperidone-associated hyperprolactinemia: evaluation in twenty psychiatric outpatients.” by S. Brunelleschi were published in Psychopharmacological Research (the official journal of the Italian Pharmacological Society), aiming to elucidate a potential link between use of Risperdal (risperidone) and hyperprolactinemia (elevated prolactin levels).  For clarity, prolactin is the hormone responsible… Continue Reading

2010 – Risperdal raises prolactin in both male and female patients

Posted in Risperdal

In 2010, a team of researchers led by N. Yasui-Furukori et al. published the results of a study titled “Gender-specific prolactin response to antipsychotic treatments with risperidone and olanzapine and its relationship to drug concentrations in patients with acutely exacerbated schizophrenia.” in Progress in Neuro-psychopharmacology & Biological Psychiatry that aimed to determine the extent of… Continue Reading

Pradaxa lawsuit shows company wanted to bury damaging data

Posted in Pradaxa

It never ceases to amaze me that some people refuse to believe that corporations intentionally suppress safety information about their products due to marketing concerns.  Unfortunately, it keeps happening again, and again, and again.  This time, with Pradaxa: Publishing the research results, she warned, could make it “extremely difficult” for the company to defend its… Continue Reading

2004 – 53% of LAP-BAND patients underwent reoperation

Posted in Allergan LAP-BAND

We are no longer accepting cases regarding these products.  Due to a terrible Supreme Court ruling, consumers injured by this product are no longer permitted to sue the manufacturers of this device.  We wish we could help, but the Supreme Court has taken the rights of citizens away to protect the profits of medical device… Continue Reading